Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

This study has been terminated.
(funding unavailable)
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00577694
First received: December 19, 2007
Last updated: October 7, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2015
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)